TAB-CEL
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 07 Jul 2025)
What this means for you
Registered since 11 Sept 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87692276
- Registration number
- 5562682
- Mark type
- Stylized text
- Filed
- 20 Nov 2017
- Published for opposition
- 06 Mar 2018
- Registered
- 11 Sept 2018
- Attorney of record
- David E. Heisey
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical and therapeutic preparations for the treatment of patients with chronic diseases, namely, cancer, kidney disease, diabetes, cachexia, age related sarcopenia, and protein-energy wasting, to be used for pharmaceutical preparations for treatment of rheumatoid arthritis and psoriasis
Owner
- PIERRE FABRE MEDICAMENT, LAVAUR, FR
- Atara Biotherapeutics, Inc., Thousand Oaks, CA, US
- Atara Biotherapeutics, Inc., South San Francisco, CA, US
- Atara Biotherapeutics, Inc., South San Francisco, CA, US
Prosecution history
- 07 Jul 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 07 Jul 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 07 Jul 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 07 Mar 2025 — TEAS SECTION 8 & 15 RECEIVED
- 24 Apr 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 11 Sept 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 24 May 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 24 May 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 24 May 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 24 May 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 24 May 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 11 Sept 2018 — REGISTERED-PRINCIPAL REGISTER
- 10 Aug 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 Aug 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 09 Jun 2018 — STATEMENT OF USE PROCESSING COMPLETE